1. The different effects of recombinant human tumor necrosis factor on rat fibrosarcoma sublines

   • Junichi Ishihara
   • Nagahiro Saijo
   • Terumi Takahashi

   Original Articles Pages: 185 - 189

2. Influence of α-interferon therapy on blood lymphoid cells

   • Stefan Einhorn
   • Patrik Ling
   • Jerzy Wasserman

   Original Articles Pages: 190 - 196

3. Canine lymphoma-associated antigens defined by murine monoclonal antibodies

   • Zenon Steplewski
   • K. Ann Jeglum
   • Nancy Weintraub

   Original Articles Pages: 197 - 201

4. Comparison of multiple anti-CEA immunotoxins active against human adenocarcinoma cells

   • Larissa V. Levin
   • Thomas W. Griffin
   • Darrow E. Haagensen Jr.

   Original Articles Pages: 202 - 206

5. Oncostatic and immunomodulatory effects of a glycoprotein fraction from water extract of abalone, Haliotis discus hannai

   • Hiroyuki Uchida
   • Takuma Sasaki
   • Hisao Kamiya

   Original Articles Pages: 207 - 212

6. Natural killer (NK) cell immunodeficiency in patients with chronic myelogenous leukemia

   • Yoshiaki Fujimiya
   • Weng-Cheng Chang
   • Paul K. Pattengale

   Original Articles Pages: 213 - 220

7. High-dose, unlabeled, nonspecific antibody pretreatment: influence on specific antibody localization to human melanoma xenografts

   • Richard L. Wahl
   • Barry S. Wilson
   • William H. Beierwaltes

   Original Articles Pages: 221 - 224

8. In vivo delayed rejection of tumors and inhibition of delayed - type hypersensitivity by HT-29 human colonic adenocarcinoma cell line

   • Gilbert J. Pommier
   • Françoise L. Garrouste
   • Maryse M. Remacle-Bonnet

   Original Articles Pages: 225 - 230

9. Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma

   • Margaret Nelson
   • D. S. Nelson
   • P. A. Jennings

   Original Articles Pages: 231 - 236

10. Defective T helper activity in the spleen of BALB/c mice immune to a syngeneic fibrosarcoma

    • Laura Grazioli
    • Marialuisa Sensi
    • Giorgio Parmiani

    Original Articles Pages: 237 - 243

11. Phase II trial of MVE-II in metastic malignant melanoma

    • John Rinehart
    • Julie LaForge
    • James Neidhart

    Original Articles Pages: 244 - 246

12. Lysosome rich cells contain the lytic activity of lymphokine-activated killer cell populations

    • Ravin Agah
    • Hungyi Shau
    • Amitabha Mazumder

    Original Articles Pages: 247 - 252

13. Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2

    • Wladyslaw Budzynski
    • Michael Chirigos
    • Eilene Gruys

    Original Articles Pages: 253 - 258

14. Augmentation of the generation of cell-mediated cytotoxicity in culture by mitomycin C

    • Tsuyoshi Akiyoshi
    • Shinya Arinaga
    • Hideo Tsuji

    Original Articles Pages: 259 - 262

15. A monoclonal antibody (Po66) directed against human lung squamous cell carcinoma immunolocalization of tumour xenografts in nude mice

    • Léontine Dazord
    • Dominique Bourel
    • Louis Toujas

    Original Articles Pages: 263 - 268

16. The anti-tumour efficacy of human recombinant interleukin 2

    • J. Bubeník
    • M. Indrová

    Original Articles Pages: 269 - 271

17. Expression of HLA-DR antigens on tumour cells does not contribute to skin reactivity to autologous cholesteryl hemisuccinate (CHS)-treated tumour cells in patients with metastatic melanoma

    • Marta Munzarová
    • Daniela Zemanová
    • Jiří Bártek

    Short Communication Pages: 272 - 274